<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Genes &amp; Cells</journal-id><journal-title-group><journal-title xml:lang="en">Genes &amp; Cells</journal-title><trans-title-group xml:lang="ru"><trans-title>Гены и Клетки</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title>Genes and Cells</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2313-1829</issn><issn publication-format="electronic">2500-2562</issn><publisher><publisher-name xml:lang="en">Human Stem Cells Institute</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">562791</article-id><article-id pub-id-type="doi">10.23868/gc562791</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Reviews</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Научные обзоры</subject></subj-group><subj-group subj-group-type="article-type"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Contribution of 25-hydroxycholesterol to the cross-interaction of the immune and nervous systems</article-title><trans-title-group xml:lang="ru"><trans-title>Вклад 25-гидроксихолестерина в перекрёстное взаимодействие иммунной и нервной систем</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2949-0026</contrib-id><contrib-id contrib-id-type="spin">9856-1498</contrib-id><name-alternatives><name xml:lang="en"><surname>Zakyrjanova</surname><given-names>Guzalia F.</given-names></name><name xml:lang="ru"><surname>Закирьянова</surname><given-names>Гузалия Фаритовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Biol.)</p></bio><bio xml:lang="ru"><p>к.б.н.</p></bio><email>farraguz12@gmail.com</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4611-7509</contrib-id><contrib-id contrib-id-type="spin">2071-9047</contrib-id><name-alternatives><name xml:lang="en"><surname>Tsentsevitsky</surname><given-names>Andrei N.</given-names></name><name xml:lang="ru"><surname>Ценцевицкий</surname><given-names>Андрей Николаевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Biol.)</p></bio><bio xml:lang="ru"><p>к.б.н.</p></bio><email>atsen@list.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4789-1800</contrib-id><contrib-id contrib-id-type="spin">7614-5148</contrib-id><name-alternatives><name xml:lang="en"><surname>Giniatullin</surname><given-names>Arthur  R.</given-names></name><name xml:lang="ru"><surname>Гиниатуллин</surname><given-names>Артур Рауфович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Biol.)</p></bio><bio xml:lang="ru"><p>к.б.н.</p></bio><email>kvestor80@rambler.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8092-9431</contrib-id><name-alternatives><name xml:lang="en"><surname>Nghomsi</surname><given-names>Sonia Madeleine Fogaing</given-names></name><name xml:lang="ru"><surname>Нгомси</surname><given-names>Соня Маделен Фоген</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>danicastats@gmail.com</email><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5581-7793</contrib-id><name-alternatives><name xml:lang="en"><surname>Kuznetsova</surname><given-names>Eva A.</given-names></name><name xml:lang="ru"><surname>Кузнецова</surname><given-names>Ева Андреевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>eva.korshak@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1432-3455</contrib-id><contrib-id contrib-id-type="spin">7543-0918</contrib-id><name-alternatives><name xml:lang="en"><surname>Petrov</surname><given-names>Alexey M.</given-names></name><name xml:lang="ru"><surname>Петров</surname><given-names>Алексей Михайлович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Dr. Sci. (Biol.)</p></bio><bio xml:lang="ru"><p>д.б.н.</p></bio><email>apneurosci@gmail.com</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Kazan Institute of Biochemistry and Biophysics, Federal Research Center “Kazan Scientific Center of RAS”, Russian Academy of Sciences</institution></aff><aff><institution xml:lang="ru">Казанский институт биохимии и биофизики — обособленное структурное подразделение Федерального исследовательского центра «Казанский научный центр Российской академии наук»</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Kazan State Medial University</institution></aff><aff><institution xml:lang="ru">Казанский государственный медицинский университет</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Кazan Federal University</institution></aff><aff><institution xml:lang="ru">Казанский федеральный университет</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2023-11-01" publication-format="electronic"><day>01</day><month>11</month><year>2023</year></pub-date><pub-date date-type="pub" iso-8601-date="2023-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2023</year></pub-date><volume>18</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>269</fpage><lpage>280</lpage><history><date date-type="received" iso-8601-date="2023-07-21"><day>21</day><month>07</month><year>2023</year></date><date date-type="accepted" iso-8601-date="2023-08-19"><day>19</day><month>08</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2023, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2023, Эко-Вектор</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2027-02-20"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref></license></permissions><self-uri xlink:href="https://genescells.ru/2313-1829/article/view/562791">https://genescells.ru/2313-1829/article/view/562791</self-uri><abstract xml:lang="en"><p>25-hydroxycholesterol (25HC) is produced from cholesterol by cholesterol-25-hydroxylase, and its expression, similar to the 25HC level, increases significantly in macrophages, dendritic cells, and microglia during an inflammatory reaction. In turn, 25HC acts on many immune cells; therefore, it can modulate the course of the inflammatory reaction and prevent the penetration of viruses into cells. Data are accumulating about the involvement of 25HC in the regulation of synaptic transmission in both the central and peripheral nervous systems. 25HC production is increased not only during inflammation but in certain neurodegenerative diseases, such as Alzheimer’s disease and amyotrophic lateral sclerosis; thus, this hydroxycholesterol can be important in the adaptation of synaptic activity to inflammatory conditions, pathogenesis of neurodegenerative diseases, and formation of synaptic dysfunctions. The targets of 25HC in the nervous system are glutamate NMDA receptors, liver X-receptors, and estrogen receptors. 25HC can also directly influence the properties of synaptic membranes by changing the formation of membrane microdomains (lipid rafts) where proteins, which are important for synaptic plasticity, are clustered. Current data indicate that the effects of 25HC strongly depend on its concentration and “context” (norm, pathology, and presence of an inflammatory reaction) in which the effect of 25HC is being investigated. This minireview focused on the key aspects of the action of 25HC as both a local regulator of cholesterol homeostasis and a paracrine molecule that realizes the influence of inflammation on neurotransmission processes in the central and peripheral nervous systems.</p></abstract><trans-abstract xml:lang="ru"><p>25-гидроксихолестерин (25ГХ) образуется из холестерина при участии фермента холестерин-25-гидроксилазы, экспрессия которой, как и уровень 25ГХ, значительно увеличивается в макрофагах, дендритных клетках и микроглии при воспалительной реакции. В свою очередь 25ГХ действует на многие иммунные клетки, модулируя течение воспалительной реакции и препятствуя проникновению вирусов в клетки. Накапливаются данные об участии 25ГХ в регуляции синаптической передачи как в центральной, так и периферической нервной системах. Учитывая повышенную продукцию 25ГХ не только при воспалении, но при ряде нейродегенеративных заболеваний (болезни Альцгеймера и боковом амиотрофическом склерозе), этот гидроксихолестерин может иметь значение в адаптации синаптической активности к воспалительным условиям, а также участвовать в патогенезе нейродегенеративных заболеваний и формировании синаптических дисфункций. Мишенями 25ГХ в нервной системе являются глутаматные NMDA-рецепторы, печёночные Х-рецепторы и эстрогеновые рецепторы. К тому же 25ГХ может напрямую влиять на свойства синаптических мембран, изменяя формирование мембранных микродоменов (липидных рафтов) — компартментов, где сосредоточены белки, важные в синаптической пластичности. Текущие данные указывают на то, что эффекты 25ГХ сильно зависят от концентрации и «контекста» (норма, патология, наличие воспалительной реакции), в котором исследуется его действие.</p> <p>В данном мини-обзоре мы сфокусировались на ключевых аспектах действия 25ГХ как локального регулятора гомеостаза холестерина и как паракринной молекулы, реализующей влияние воспаления на процессы нейропередачи в центральной и периферической нервной системе.</p></trans-abstract><kwd-group xml:lang="en"><kwd>synaptic transmission</kwd><kwd>25-hydroxycholesterol</kwd><kwd>skeletal muscle</kwd><kwd>vesicle</kwd><kwd>lipid rafts</kwd><kwd>neurotransmitter</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>синаптическая передача</kwd><kwd>25-гидроксихолестерин</kwd><kwd>скелетная мышца</kwd><kwd>везикула</kwd><kwd>липидные рафты</kwd><kwd>нейромедиатор</kwd></kwd-group><funding-group><funding-statement xml:lang="en">This work was supported by the Research Foundation Flanders (grant N 23-75-10022)</funding-statement><funding-statement xml:lang="ru">Научное исследование проведено при поддержке Российского научного фонда (грант № 23-75-10022)</funding-statement></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">Lipowsky R, Sackmsnn E, editors. Structure and dynamics of membranes. 1st ed. Elsevier; 1995. 1052 p.</mixed-citation><mixed-citation xml:lang="ru">Lipowsky R., Sackmsnn E., editors. Structure and dynamics of membranes. 1st ed. Elsevier, 1995. 1052 p.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">Ma L, Nelson ER. Oxysterols and nuclear receptors. Mol Cell Endocrinol. 2019;484:42–51. doi: 10.1016/j.mce.2019.01.016</mixed-citation><mixed-citation xml:lang="ru">Ma L., Nelson E.R. Oxysterols and nuclear receptors // Mol Cell Endocrinol. 2019. Vol. 484. P. 42–51. doi: 10.1016/j.mce.2019.01.016</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">Olivier E, Dutot M, Regazzetti A, et al. P2X7-pannexin-1 and amyloid β-induced oxysterol input in human retinal cell: role in age-related macular degeneration? Biochimie. 2016;127:70–78. doi: 10.1016/j.biochi.2016.04.014</mixed-citation><mixed-citation xml:lang="ru">Olivier E., Dutot M., Regazzetti A., et al. P2X7-pannexin-1 and amyloid β-induced oxysterol input in human retinal cell: Role in age-related macular degeneration? // Biochimie. 2016. Vol. 127. P. 70–78. doi: 10.1016/j.biochi.2016.04.014</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">Bezine M, Namsi A, Sghaier R, et al. The effect of oxysterols on nerve impulses. Biochimie. 2018;153:46–51. doi: 10.1016/j.biochi.2018.04.013</mixed-citation><mixed-citation xml:lang="ru">Bezine M., Namsi A., Sghaier R., et al. The effect of oxysterols on nerve impulses // Biochimie. 2018. Vol. 153. P. 46–51. doi: 10.1016/j.biochi.2018.04.013</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">Gargiulo S, Gamba P, Testa G, et al. Molecular signaling involved in oxysterol-induced β₁-integrin over-expression in human macrophages. Int J Mol Sci. 2012;13(11):14278–14293. doi: 10.3390/ijms131114278</mixed-citation><mixed-citation xml:lang="ru">Gargiulo S., Gamba P., Testa G., et al. Molecular signaling involved in oxysterol-induced β₁-integrin over-expression in human macrophages // Int J Mol Sci. 2012. Vol. 13, N 11. P. 14278–14293. doi: 10.3390/ijms131114278</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">Yan D, Mäyränpää MI, Wong J, et al. OSBP-related protein 8 (ORP8) suppresses ABCA1 expression and cholesterol efflux from macrophages. J Biol Chem. 2008;283(1):332–340. doi: 10.1074/jbc.M705313200</mixed-citation><mixed-citation xml:lang="ru">Yan D., Mäyränpää M.I., Wong J., et al. OSBP-related protein 8 (ORP8) suppresses ABCA1 expression and cholesterol efflux from macrophages // J Biol Chem. 2008. Vol. 283, N 1. P. 332–340. doi: 10.1074/jbc.M705313200</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">Kasimov MR, Fatkhrakhmanova MR, Mukhutdinova KA, Petrov AM. 24S-hydroxycholesterol enhances synaptic vesicle cycling in the mouse neuromuscular junction: implication of glutamate NMDA receptors and nitric oxide. Neuropharmacology. 2017;117:61–73. doi: 10.1016/j.neuropharm.2017.01.030</mixed-citation><mixed-citation xml:lang="ru">Kasimov M.R., Fatkhrakhmanova M.R., Mukhutdinova K.A., Petrov A.M. 24S-hydroxycholesterol enhances synaptic vesicle cycling in the mouse neuromuscular junction: Implication of glutamate NMDA receptors and nitric oxide // Neuropharmacology. 2017. Vol. 117. P. 61–73. doi: 10.1016/j.neuropharm.2017.01.030</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">Mukhutdinova KA, Kasimov MR, Giniatullin AR, et al. 24S-hydroxycholesterol suppresses neuromuscular transmission in SOD1(G93A) mice: a possible role of NO and lipid rafts. Mol Cell Neurosci. 2018;88:308–318. doi: 10.1016/j.mcn.2018.03.006</mixed-citation><mixed-citation xml:lang="ru">Mukhutdinova K.A., Kasimov M.R., Giniatullin A.R., et al. 24S-hydroxycholesterol suppresses neuromuscular transmission in SOD1(G93A) mice: a possible role of NO and lipid rafts // Mol Cell Neurosci. 2018. Vol. 88. P. 308–318. doi: 10.1016/j.mcn.2018.03.006</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">Mukhutdinova KA, Kasimov MR, Zakyrjanova GF, et al. Oxysterol modulates neurotransmission via liver-X receptor/NO synthase-dependent pathway at the mouse neuromuscular junctions. Neuropharmacology. 2019;150:70–79. doi: 10.1016/j.neuropharm.2019.03.018</mixed-citation><mixed-citation xml:lang="ru">Mukhutdinova K.A., Kasimov M.R., Zakyrjanova G.F., et al. Oxysterol modulates neurotransmission via liver-X receptor/NO synthase-dependent pathway at the mouse neuromuscular junctions // Neuropharmacology. 2019. Vol. 150. P. 70–79. doi: 10.1016/j.neuropharm.2019.03.018</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">Petrov AM, Pikuleva IA. Cholesterol 24-hydroxylation by CYP46A1: benefits of modulation for brain diseases. Neurotherapeutics. 2019;16(3):635–648. doi: 10.1007/s13311-019-00731-6</mixed-citation><mixed-citation xml:lang="ru">Petrov A.M., Pikuleva I.A. Cholesterol 24-hydroxylation by CYP46A1: benefits of modulation for brain diseases // Neurotherapeutics. 2019. Vol. 16, N 3. P. 635–648. doi: 10.1007/s13311-019-00731-6</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">Lütjohann D, Breuer O, Ahlborg G, et al. Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. Proc Natl Acad Sci U S A. 1996;93(18):9799–9804. doi: 10.1073/pnas.93.18.9799</mixed-citation><mixed-citation xml:lang="ru">Lütjohann D., Breuer O., Ahlborg G., et al. Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation // Proc Natl Acad Sci U S A. 1996. Vol. 93, N 18. P. 9799–9804. doi: 10.1073/pnas.93.18.9799</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">Meaney S, Bodin K, Diczfalusy U, Björkhem I. On the rate of translocation in vitro and kinetics in vivo of the major oxysterols in human circulation: critical importance of the position of the oxygen function. J Lipid Res. 2002;43(12):2130–2135. doi: 10.1194/jlr.m200293-jlr200</mixed-citation><mixed-citation xml:lang="ru">Meaney S., Bodin K., Diczfalusy U., Björkhem I. On the rate of translocation in vitro and kinetics in vivo of the major oxysterols in human circulation: critical importance of the position of the oxygen function // J Lipid Res. 2002. Vol. 43, N 12. P. 2130–2135. doi: 10.1194/jlr.M200293-JLR200</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">Lund EG, Xie C, Kotti T, et al. Knockout of the cholesterol 24-hydroxylase gene in mice reveals a brain-specific mechanism of cholesterol turnover. J Biol Chem. 2003;278(25):22980–22988. doi: 10.1074/jbc.M303415200</mixed-citation><mixed-citation xml:lang="ru">Lund E.G., Xie C., Kotti T., et al. Knockout of the cholesterol 24-hydroxylase gene in mice reveals a brain-specific mechanism of cholesterol turnover // J Biol Chem. 2003. Vol. 278, N 25. P. 22980–22988. doi: 10.1074/jbc.M303415200</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">Björkhem I, Lütjohann D, Diczfalusy U, et al. Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. J Lipid Res. 1998;39(8):1594–1600.</mixed-citation><mixed-citation xml:lang="ru">Björkhem I., Lütjohann D., Diczfalusy U., et al. Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation // J Lipid Res. 1998. Vol. 39, N 8. P. 1594–1600.</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">Blanc M, Hsieh WY, Robertson KA, et al. The transcription factor STAT-1 couples macrophage synthesis of 25-hydroxycholesterol to the interferon antiviral response. Immunity. 2013;38(1):106–118. doi: 10.1016/j.immuni.2012.11.004</mixed-citation><mixed-citation xml:lang="ru">Blanc M., Hsieh W.Y., Robertson K.A., et al. The transcription factor STAT-1 couples macrophage synthesis of 25-hydroxycholesterol to the interferon antiviral response // Immunity. 2013. Vol. 38, N 1. P. 106–118. doi: 10.1016/j.immuni.2012.11.004</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">Liu Y, Wei Z, Ma X, et al. 25-hydroxycholesterol activates the expression of cholesterol 25-hydroxylase in an LXR-dependent mechanism. J Lipid Res. 2018;59(3):439–451. doi: 10.1194/jlr.M080440</mixed-citation><mixed-citation xml:lang="ru">Liu Y., Wei Z., Ma X., et al. 25-Hydroxycholesterol activates the expression of cholesterol 25-hydroxylase in an LXR-dependent mechanism // J Lipid Res. 2018. Vol. 59, N 3. P. 439–451. doi: 10.1194/jlr.M080440</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">Bauman DR, Bitmansour AD, McDonald JG, et al. 25-hydroxycholesterol secreted by macrophages in response to Toll-like receptor activation suppresses immunoglobulin A production. Proc Natl Acad Sci U S A. 2009;106(39):16764–16769. doi: 10.1073/pnas.0909142106</mixed-citation><mixed-citation xml:lang="ru">Bauman D.R., Bitmansour A.D., McDonald J.G., et al. 25-hydroxycholesterol secreted by macrophages in response to Toll-like receptor activation suppresses immunoglobulin A production // Proc Natl Acad Sci U S A. 2009. Vol. 106, N 39. P. 16764–16769. doi: 10.1073/pnas.0909142106</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">Karuna R, Christen I, Sailer AW, et al. Detection of dihydroxycholesterols in human plasma using HPLC-ESI-MS/MS. Steroids. 2015;99(Pt B):131–138. doi: 10.1016/j.steroids.2015.02.002</mixed-citation><mixed-citation xml:lang="ru">Karuna R., Christen I., Sailer A.W., et al. Detection of dihydroxycholesterols in human plasma using HPLC-ESI-MS/MS // Steroids. 2015. Vol. 99(Pt B). P. 131–138. doi: 10.1016/j.steroids.2015.02.002</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">Lehmann JM, Kliewer SA, Moore LB, et al. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J Biol Chem. 1997;272(6):3137–3140. doi: 10.1074/jbc.272.6.3137</mixed-citation><mixed-citation xml:lang="ru">Lehmann J.M., Kliewer S.A., Moore L.B., et al. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway // J Biol Chem. 1997. Vol. 272, N 6. P. 3137–3140. doi: 10.1074/jbc.272.6.3137</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">Zhu R, Ou Z, Ruan X, Gong J. Role of liver X receptors in cholesterol efflux and inflammatory signaling (review). Mol Med Rep. 2012;5(4):895–900. doi: 10.3892/mmr.2012.758</mixed-citation><mixed-citation xml:lang="ru">Zhu R., Ou Z., Ruan X., Gong J. Role of liver X receptors in cholesterol efflux and inflammatory signaling (review) // Mol Med Rep. 2012. Vol. 5, N 4. P. 895–900. doi: 10.3892/mmr.2012.758</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><citation-alternatives><mixed-citation xml:lang="en">Ouyang S, Mo Z, Sun S, et al. Emerging role of Insig-1 in lipid metabolism and lipid disorders. Clin Chim Acta. 2020;508:206–212. doi: 10.1016/j.cca.2020.05.042</mixed-citation><mixed-citation xml:lang="ru">Ouyang S., Mo Z., Sun S., et al. Emerging role of Insig-1 in lipid metabolism and lipid disorders // Clin Chim Acta. 2020. Vol. 508. P. 206–212. doi: 10.1016/j.cca.2020.05.042</mixed-citation></citation-alternatives></ref><ref id="B22"><label>22.</label><citation-alternatives><mixed-citation xml:lang="en">Radhakrishnan A, Ikeda Y, Kwon HJ, et al. Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: oxysterols block transport by binding to INSIG. Proc Natl Acad Sci U S A. 2007;104(16):6511–6518. doi: 10.1073/pnas.0700899104</mixed-citation><mixed-citation xml:lang="ru">Radhakrishnan A., Ikeda Y., Kwon H.J., et al. Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: oxysterols block transport by binding to INSIG // Proc Natl Acad Sci U S A. 2007. Vol. 104, N 16. P. 6511–6518. doi: 10.1073/pnas.0700899104</mixed-citation></citation-alternatives></ref><ref id="B23"><label>23.</label><citation-alternatives><mixed-citation xml:lang="en">Sever N, Yang T, Brown MS, et al. Accelerated degradation of HMG CoA reductase mediated by binding of INSIG-1 to its sterol-sensing domain. Mol Cell. 2003;11(1):25–33. doi: 10.1016/s1097-2765(02)00822-5</mixed-citation><mixed-citation xml:lang="ru">Sever N., Yang T., Brown M.S., et al. Accelerated degradation of HMG CoA reductase mediated by binding of INSIG-1 to its sterol-sensing domain // Mol Cell. 2003. Vol. 11, N 1. P. 25–33. doi: 10.1016/S1097-2765(02)00822-5</mixed-citation></citation-alternatives></ref><ref id="B24"><label>24.</label><citation-alternatives><mixed-citation xml:lang="en">Morens DM, Fauci AS. The 1918 influenza pandemic: insights for the 21st century. J Infect Dis. 2007;195(7):1018–1028. doi: 10.1086/511989</mixed-citation><mixed-citation xml:lang="ru">Morens D.M., Fauci A.S. The 1918 influenza pandemic: insights for the 21st century // J Infect Dis. 2007. Vol. 195, N 7. P. 1018–1028. doi: 10.1086/511989</mixed-citation></citation-alternatives></ref><ref id="B25"><label>25.</label><citation-alternatives><mixed-citation xml:lang="en">Kobasa D, Jones SM, Shinya K, et al. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature. 2007;445(7125):319–323. doi: 10.1038/nature05495</mixed-citation><mixed-citation xml:lang="ru">Kobasa D., Jones S.M., Shinya K., et al. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus // Nature. 2007. Vol. 445, N 7125. P. 319–323. doi: 10.1038/nature05495</mixed-citation></citation-alternatives></ref><ref id="B26"><label>26.</label><citation-alternatives><mixed-citation xml:lang="en">Joseph SB, Bradley MN, Castrillo A, et al. LXR-dependent gene expression is important for macrophage survival and the innate immune response. Cell. 2004;119(2):299–309. doi: 10.1016/j.cell.2004.09.032</mixed-citation><mixed-citation xml:lang="ru">Joseph S.B., Bradley M.N., Castrillo A., et al. LXR-dependent gene expression is important for macrophage survival and the innate immune response // Cell. 2004. Vol. 119, N 2. P. 299–309. doi: 10.1016/j.cell.2004.09.032</mixed-citation></citation-alternatives></ref><ref id="B27"><label>27.</label><citation-alternatives><mixed-citation xml:lang="en">Reboldi A, Dang EV, McDonald JG, et al. Inflammation. 25-hydroxycholesterol suppresses interleukin-1-driven inflammation downstream of type I interferon. Science. 2014;345(6197):679–684. doi: 10.1126/science.1254790</mixed-citation><mixed-citation xml:lang="ru">Reboldi A., Dang E.V., McDonald J.G., et al. Inflammation. 25-hydroxycholesterol suppresses interleukin-1-driven inflammation downstream of type I interferon // Science. 2014. Vol. 345, N 6197. P. 679–684. doi: 10.1126/science.1254790</mixed-citation></citation-alternatives></ref><ref id="B28"><label>28.</label><citation-alternatives><mixed-citation xml:lang="en">Liu SY, Aliyari R, Chikere K, et al. Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol. Immunity. 2013;38(1):92–105. doi: 10.1016/j.immuni.2012.11.005</mixed-citation><mixed-citation xml:lang="ru">Liu S.Y., Aliyari R., Chikere K., et al. Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol // Immunity. 2013. Vol. 38, N 1. P. 92–105. doi: 10.1016/j.immuni.2012.11.005</mixed-citation></citation-alternatives></ref><ref id="B29"><label>29.</label><citation-alternatives><mixed-citation xml:lang="en">Liu Y, Wei Z, Zhang Y, et al. Activation of liver X receptor plays a central role in antiviral actions of 25-hydroxycholesterol. J Lipid Res. 2018;59(12):2287–2296. doi: 10.1194/jlr.M084558</mixed-citation><mixed-citation xml:lang="ru">Liu Y., Wei Z., Zhang Y., et al. Activation of liver X receptor plays a central role in antiviral actions of 25-hydroxycholesterol // J Lipid Res. 2018. Vol. 59, N 12. P. 2287–2296. doi: 10.1194/jlr.M084558</mixed-citation></citation-alternatives></ref><ref id="B30"><label>30.</label><citation-alternatives><mixed-citation xml:lang="en">Yuan Y, Wang Z, Tian B, et al. Cholesterol 25-hydroxylase suppresses rabies virus infection by inhibiting viral entry. Arch Virol. 2019;164(12):2963–2974. doi: 10.1007/s00705-019-04415-6</mixed-citation><mixed-citation xml:lang="ru">Yuan Y., Wang Z., Tian B., et al. Cholesterol 25-hydroxylase suppresses rabies virus infection by inhibiting viral entry // Arch Virol. 2019. Vol. 164, N 12. P. 2963–2974. doi: 10.1007/s00705-019-04415-6</mixed-citation></citation-alternatives></ref><ref id="B31"><label>31.</label><citation-alternatives><mixed-citation xml:lang="en">Wong MY, Lewis M, Doherty JJ, et al. 25-hydroxycholesterol amplifies microglial IL-1β production in an apoE isoform-dependent manner. J Neuroinflammation. 2020;17(1):192. doi: 10.1186/s12974-020-01869-3</mixed-citation><mixed-citation xml:lang="ru">Wong M.Y., Lewis M., Doherty J.J., et al. 25-hydroxycholesterol amplifies microglial IL-1β production in an apoE isoform-dependent manner // J Neuroinflammation. 2020. Vol. 17, N 1. P. 192. doi: 10.1186/s12974-020-01869-3</mixed-citation></citation-alternatives></ref><ref id="B32"><label>32.</label><citation-alternatives><mixed-citation xml:lang="en">Izumi Y, Cashikar AG, Krishnan K, et al. A proinflammatory stimulus disrupts hippocampal plasticity and learning via microglial activation and 25-hydroxycholesterol. J Neurosci. 2021;41(49):10054–10064. doi: 10.1523/JNEUROSCI.1502-21.2021</mixed-citation><mixed-citation xml:lang="ru">Izumi Y., Cashikar A.G., K., et al. A proinflammatory stimulus disrupts hippocampal plasticity and learning via microglial activation and 25-hydroxycholesterol // J Neurosci. 2021. Vol. 41, N 49. P. 10054–10064. doi: 10.1523/JNEUROSCI.1502-21.2021</mixed-citation></citation-alternatives></ref><ref id="B33"><label>33.</label><citation-alternatives><mixed-citation xml:lang="en">Linsenbardt AJ, Taylor A, Emnett CM, et al. Different oxysterols have opposing actions at N-methyl-D-aspartate receptors. Neuropharmacology. 2014;85:232–242. doi: 10.1016/j.neuropharm.2014.05.027</mixed-citation><mixed-citation xml:lang="ru">Linsenbardt A.J., Taylor A., Emnett C.M., et al. Different oxysterols have opposing actions at N-methyl-D-aspartate receptors // Neuropharmacology. 2014. Vol. 85. P. 232–242. doi: 10.1016/j.neuropharm.2014.05.027</mixed-citation></citation-alternatives></ref><ref id="B34"><label>34.</label><citation-alternatives><mixed-citation xml:lang="en">Ishikawa T, Yuhanna IS, Umetani J, et al. LXRβ/estrogen receptor-α signaling in lipid rafts preserves endothelial integrity. J Clin Invest. 2013;123(8):3488–3497. doi: 10.1172/JCI66533</mixed-citation><mixed-citation xml:lang="ru">Ishikawa T., Yuhanna I.S., Umetani J., et al. LXRβ/estrogen receptor-α signaling in lipid rafts preserves endothelial integrity // J Clin Invest. 2013. Vol. 123, N 8. P. 3488–3497. doi: 10.1172/JCI66533</mixed-citation></citation-alternatives></ref><ref id="B35"><label>35.</label><citation-alternatives><mixed-citation xml:lang="en">Clements L, Harvey J. Activation of oestrogen receptor α induces a novel form of LTP at hippocampal temporoammonic-CA1 synapses. Br J Pharmacol. 2020;177(3):642–655. doi: 10.1111/bph.14880</mixed-citation><mixed-citation xml:lang="ru">Clements L., Harvey J. Activation of oestrogen receptor α induces a novel form of LTP at hippocampal temporoammonic-CA1 synapses // Br J Pharmacol. 2020. Vol. 177, N 3. P. 642–655. doi: 10.1111/bph.14880</mixed-citation></citation-alternatives></ref><ref id="B36"><label>36.</label><citation-alternatives><mixed-citation xml:lang="en">Zakyrjanova GF, Tsentsevitsky AN, Kuznetsova EA, Petrov AM. Immune-related oxysterol modulates neuromuscular transmission via non-genomic liver X receptor-dependent mechanism. Free Radic Biol Med. 2021;174:121–134. doi: 10.1016/j.freeradbiomed.2021.08.013</mixed-citation><mixed-citation xml:lang="ru">Zakyrjanova G.F., Tsentsevitsky A.N., Kuznetsova E.A., Petrov A.M. Immune-related oxysterol modulates neuromuscular transmission via non-genomic liver X receptor-dependent mechanism // Free Radic Biol Med. 2021. Vol. 174. P. 121–134. doi: 10.1016/j.freeradbiomed.2021.08.013</mixed-citation></citation-alternatives></ref><ref id="B37"><label>37.</label><citation-alternatives><mixed-citation xml:lang="en">Unsworth AJ, Flora GD, Gibbins JM. Non-genomic effects of nuclear receptors: insights from the anucleate platelet. Cardiovasc Res. 2018;114(5):645–655. doi: 10.1093/cvr/cvy044</mixed-citation><mixed-citation xml:lang="ru">Unsworth A.J., Flora G.D., Gibbins J.M. Non-genomic effects of nuclear receptors: insights from the anucleate platelet // Cardiovasc Res. 2018. Vol. 114, N 5. P. 645–655. doi: 10.1093/cvr/cvy044</mixed-citation></citation-alternatives></ref><ref id="B38"><label>38.</label><citation-alternatives><mixed-citation xml:lang="en">Bigini P, Steffensen KR, Ferrario A, et al. Neuropathologic and biochemical changes during disease progression in liver X receptor beta–/– mice, a model of adult neuron disease. J Neuropathol Exp Neurol. 2010;69(6):593–605. doi: 10.1097/NEN.0b013e3181df20e1</mixed-citation><mixed-citation xml:lang="ru">Bigini P., Steffensen K.R., Ferrario A., et al. Neuropathologic and biochemical changes during disease progression in liver X receptor beta–/– mice, a model of adult neuron disease // J Neuropathol Exp Neurol. 2010. Vol. 69, N 6. P. 593–605. doi: 10.1097/NEN.0b013e3181df20e1</mixed-citation></citation-alternatives></ref><ref id="B39"><label>39.</label><citation-alternatives><mixed-citation xml:lang="en">Hichor M, Sundaram VK, Eid SA, et al. Liver X receptor exerts a protective effect against the oxidative stress in the peripheral nerve. Sci Rep. 2018;8(1):2524. doi: 10.1038/s41598-018-20980-3</mixed-citation><mixed-citation xml:lang="ru">Hichor M., Sundaram V.K., Eid S.A., et al. Liver X receptor exerts a protective effect against the oxidative stress in the peripheral nerve // Sci Rep. 2018. Vol. 8, N 1. P. 2524. doi: 10.1038/s41598-018-20980-3</mixed-citation></citation-alternatives></ref><ref id="B40"><label>40.</label><citation-alternatives><mixed-citation xml:lang="en">Zhong W, Pan G, Wang L, et al. ORP4L facilitates macrophage survival via G-protein-coupled signaling: ORP4L–/– mice display a reduction of atherosclerosis. Circ Res. 2016;119(12):1296–1312. doi: 10.1161/CIRCRESAHA.116.309603</mixed-citation><mixed-citation xml:lang="ru">Zhong W., Pan G., Wang L., et al. ORP4L facilitates macrophage survival via G-protein-coupled signaling: ORP4L–/– mice display a reduction of atherosclerosis // Circ Res. 2016. Vol. 119, N 12. P. 1296–1312. doi: 10.1161/CIRCRESAHA.116.309603</mixed-citation></citation-alternatives></ref><ref id="B41"><label>41.</label><citation-alternatives><mixed-citation xml:lang="en">Jin YH, Wu XS, Shi B, et al. Protein kinase C and calmodulin serve as calcium sensors for calcium-stimulated endocytosis at synapses. J Neurosci. 2019;39(48):9478–9490. doi: 10.1523/JNEUROSCI.0182-19.2019</mixed-citation><mixed-citation xml:lang="ru">Jin Y.H., Wu X.S., Shi B., et al. Protein kinase c and calmodulin serve as calcium sensors for calcium-stimulated endocytosis at synapses // J Neurosci. 2019. Vol. 39, N 48. P. 9478–9490. doi: 10.1523/JNEUROSCI.0182-19.2019</mixed-citation></citation-alternatives></ref><ref id="B42"><label>42.</label><citation-alternatives><mixed-citation xml:lang="en">Kumar P, Wu Q, Chambliss KL, et al. Direct interactions with G α i and G βγ mediate nongenomic signaling by estrogen receptor α. Mol Endocrinol. 2007;21(6):1370–1380. doi: 10.1210/me.2006-0360</mixed-citation><mixed-citation xml:lang="ru">Kumar P., Wu Q., Chambliss K.L., et al. Direct interactions with G α i and G βγ mediate nongenomic signaling by estrogen receptor α // Mol Endocrinol. 2007. Vol. 21, N 6. P. 1370–1380. doi: 10.1210/me.2006-0360</mixed-citation></citation-alternatives></ref><ref id="B43"><label>43.</label><citation-alternatives><mixed-citation xml:lang="en">Görlach A, Bertram K, Hudecova S, Krizanova O. Calcium and ROS: a mutual interplay. Redox Biol. 2015;6:260–271. doi: 10.1016/j.redox.2015.08.010</mixed-citation><mixed-citation xml:lang="ru">Görlach A., Bertram K., Hudecova S., Krizanova O. Calcium and ROS: a mutual interplay // Redox Biol. 2015. Vol. 6. P. 260–271. doi: 10.1016/j.redox.2015.08.010</mixed-citation></citation-alternatives></ref><ref id="B44"><label>44.</label><citation-alternatives><mixed-citation xml:lang="en">Giniatullin AR, Giniatullin RA. Dual action of hydrogen peroxide on synaptic transmission at the frog neuromuscular junction. J Physiol. 2003;552(Pt 1):283–293. doi: 10.1113/jphysiol.2003.050690</mixed-citation><mixed-citation xml:lang="ru">Giniatullin A.R., Giniatullin R.A. Dual action of hydrogen peroxide on synaptic transmission at the frog neuromuscular junction // J Physiol. 2003. Vol. 552(Pt 1). P. 283–293. doi: 10.1113/jphysiol.2003.050690</mixed-citation></citation-alternatives></ref><ref id="B45"><label>45.</label><citation-alternatives><mixed-citation xml:lang="en">Cosentino-Gomes D, Rocco-Machado N, Meyer-Fernandes JR. Cell signaling through protein kinase C oxidation and activation. Int J Mol Sci. 2012;13(9):10697–10721. doi: 10.3390/ijms130910697</mixed-citation><mixed-citation xml:lang="ru">Cosentino-Gomes D., Rocco-Machado N., Meyer-Fernandes J.R. Cell signaling through protein kinase C oxidation and activation // Int J Mol Sci. 2012. Vol. 13, N 9. P. 10697–10721. doi: 10.3390/ijms130910697</mixed-citation></citation-alternatives></ref><ref id="B46"><label>46.</label><citation-alternatives><mixed-citation xml:lang="en">Ursan R, Odnoshivkina UG, Petrov AM. Membrane cholesterol oxidation downregulates atrial β-adrenergic responses in ROS-dependent manner. Cell Signal. 2020;67:109503. doi: 10.1016/j.cellsig.2019.109503</mixed-citation><mixed-citation xml:lang="ru">Ursan R., Odnoshivkina U.G., Petrov A.M. Membrane cholesterol oxidation downregulates atrial β-adrenergic responses in ROS-dependent manner // Cell Signal. 2020. Vol. 67. P. 109503. doi: 10.1016/j.cellsig.2019.109503</mixed-citation></citation-alternatives></ref><ref id="B47"><label>47.</label><citation-alternatives><mixed-citation xml:lang="en">Dodge JC, Yu J, Sardi SP, Shihabuddin LS. Sterol auto-oxidation adversely affects human motor neuron viability and is a neuropathological feature of amyotrophic lateral sclerosis. Sci Rep. 2021;11(1):803. doi: 10.1038/s41598-020-80378-y</mixed-citation><mixed-citation xml:lang="ru">Dodge J.C., Yu J., Sardi S.P., Shihabuddin L.S. Sterol auto-oxidation adversely affects human motor neuron viability and is a neuropathological feature of amyotrophic lateral sclerosis // Sci Rep. 2021. Vol. 11, N 1. P. 803. doi: 10.1038/s41598-020-80378-y</mixed-citation></citation-alternatives></ref><ref id="B48"><label>48.</label><citation-alternatives><mixed-citation xml:lang="en">Kim SM, Noh MY, Kim H, et al. 25-hydroxycholesterol is involved in the pathogenesis of amyotrophic lateral sclerosis. Oncotarget. 2017;8(7):11855–11867. doi: 10.18632/oncotarget.14416</mixed-citation><mixed-citation xml:lang="ru">Kim S.M., Noh M.Y., Kim H., et al. 25-hydroxycholesterol is involved in the pathogenesis of amyotrophic lateral sclerosis // Oncotarget. 2017. Vol. 8, N 7. P. 11855–11867. doi: 10.18632/oncotarget.14416</mixed-citation></citation-alternatives></ref><ref id="B49"><label>49.</label><citation-alternatives><mixed-citation xml:lang="en">Choi YK, Kim YS, Choi IY, et al. 25-hydroxycholesterol induces mitochondria-dependent apoptosis via activation of glycogen synthase kinase-3beta in PC12 cells. Free Radic Res. 2008;42(6):544–553. doi: 10.1080/10715760802146062</mixed-citation><mixed-citation xml:lang="ru">Choi Y.K., Kim Y.S., Choi I.Y., et al. 25-hydroxycholesterol induces mitochondria-dependent apoptosis via activation of glycogen synthase kinase-3beta in PC12 cells // Free Radic Res. 2008. Vol. 42, N 6. P. 544–553. doi: 10.1080/10715760802146062</mixed-citation></citation-alternatives></ref><ref id="B50"><label>50.</label><citation-alternatives><mixed-citation xml:lang="en">Kim SM, Kim H, Kim JE, et al. Amyotrophic lateral sclerosis is associated with hypolipidemia at the presymptomatic stage in mice. PLoS One. 2011;6(3):e17985. doi: 10.1371/journal.pone.0017985</mixed-citation><mixed-citation xml:lang="ru">Kim S.M., Kim H., Kim J.E., et al. Amyotrophic lateral sclerosis is associated with hypolipidemia at the presymptomatic stage in mice // PLoS One. 2011. Vol. 6, N 3. P. e17985. doi: 10.1371/journal.pone.0017985</mixed-citation></citation-alternatives></ref><ref id="B51"><label>51.</label><citation-alternatives><mixed-citation xml:lang="en">Chen X, Yazdani S, Piehl F, et al. Polygenic link between blood lipids and amyotrophic lateral sclerosis. Neurobiol Aging. 2018;67:202.e1–202.e6. doi: 10.1016/j.neurobiolaging.2018.03.022</mixed-citation><mixed-citation xml:lang="ru">Chen X., Yazdani S., Piehl F., et al. Polygenic link between blood lipids and amyotrophic lateral sclerosis // Neurobiol Aging. 2018. Vol. 67. P. 202. doi: 10.1016/j.neurobiolaging.2018.03.022</mixed-citation></citation-alternatives></ref><ref id="B52"><label>52.</label><citation-alternatives><mixed-citation xml:lang="en">Zakyrjanova GF, Giniatullin AR, Mukhutdinova KA, et al. Early differences in membrane properties at the neuromuscular junctions of ALS model mice: effects of 25-hydroxycholesterol. Life Sci. 2021;273:119300. doi: 10.1016/j.lfs.2021.119300</mixed-citation><mixed-citation xml:lang="ru">Zakyrjanova G.F., Giniatullin A.R., Mukhutdinova K.A., et al. Early differences in membrane properties at the neuromuscular junctions of ALS model mice: effects of 25-hydroxycholesterol // Life Sci. 2021. Vol. 273. P. 119300. doi: 10.1016/j.lfs.2021.119300</mixed-citation></citation-alternatives></ref><ref id="B53"><label>53.</label><citation-alternatives><mixed-citation xml:lang="en">Deguise MO, Baranello G, Mastella C, et al. Abnormal fatty acid metabolism is a core component of spinal muscular atrophy. Ann Clin Transl Neurol. 2019;6(8):1519–1532. doi: 10.1002/acn3.50855</mixed-citation><mixed-citation xml:lang="ru">Deguise M.O., Baranello G., Mastella C., et al. Abnormal fatty acid metabolism is a core component of spinal muscular atrophy // Ann Clin Transl Neurol. 2019. Vol. 6, N 8. P. 1519–1532. doi: 10.1002/acn3.50855</mixed-citation></citation-alternatives></ref><ref id="B54"><label>54.</label><citation-alternatives><mixed-citation xml:lang="en">Darios F, Mochel F, Stevanin G. Lipids in the physiopathology of hereditary spastic paraplegias. Front Neurosci. 2020;14:74. doi: 10.3389/fnins.2020.00074</mixed-citation><mixed-citation xml:lang="ru">Darios F., Mochel F., Stevanin G. Lipids in the physiopathology of hereditary spastic paraplegias // Front Neurosci. 2020. Vol. 14. P. 74. doi: 10.3389/fnins.2020.00074</mixed-citation></citation-alternatives></ref><ref id="B55"><label>55.</label><citation-alternatives><mixed-citation xml:lang="en">González-Guevara E, Cárdenas G, Pérez-Severiano F, Martínez-Lazcano JC. Dysregulated brain cholesterol metabolism is linked to neuroinflammation in huntington’s disease. Mov Disord. 2020;35(7):1113–1127. doi: 10.1002/mds.28089</mixed-citation><mixed-citation xml:lang="ru">González-Guevara E., Cárdenas G., Pérez-Severiano F., Martínez-Lazcano J.C. Dysregulated brain cholesterol metabolism is linked to neuroinflammation in huntington’s disease // Mov Disord. 2020. Vol. 35, N 7. P. 1113–1127. doi: 10.1002/mds.28089</mixed-citation></citation-alternatives></ref><ref id="B56"><label>56.</label><citation-alternatives><mixed-citation xml:lang="en">Fanning S, Selkoe D, Dettmer U. Parkinson’s disease: proteinopathy or lipidopathy? NPJ Parkinsons Dis. 2020;6:3. doi: 10.1038/s41531-019-0103-7</mixed-citation><mixed-citation xml:lang="ru">Fanning S., Selkoe D., Dettmer U. Parkinson’s disease: proteinopathy or lipidopathy? // NPJ Parkinsons Dis. 2020. Vol. 6. P. 3. doi: 10.1038/s41531-019-0103-7</mixed-citation></citation-alternatives></ref><ref id="B57"><label>57.</label><citation-alternatives><mixed-citation xml:lang="en">Luchsinger JA, Cheng D, Tang MX, et al. Central obesity in the elderly is related to late-onset Alzheimer disease. Alzheimer Dis Assoc Disord. 2012;26(2):101–105. doi: 10.1097/WAD.0b013e318222f0d4</mixed-citation><mixed-citation xml:lang="ru">Luchsinger J.A., Cheng D., Tang M.X., et al. Central obesity in the elderly is related to late-onset Alzheimer disease // Alzheimer Dis Assoc Disord. 2012. Vol. 26, N 2. P. 101–105. doi: 10.1097/WAD.0b013e318222f0d4</mixed-citation></citation-alternatives></ref><ref id="B58"><label>58.</label><citation-alternatives><mixed-citation xml:lang="en">Tolppanen AM, Ngandu T, Kåreholt I, et al. Midlife and late-life body mass index and late-life dementia: results from a prospective population-based cohort. J Alzheimers Dis. 2014;38(1):201–209. doi: 10.3233/JAD-130698</mixed-citation><mixed-citation xml:lang="ru">Tolppanen A.M., Ngandu T., Kåreholt I., et al. Midlife and late-life body mass index and late-life dementia: results from a prospective population-based cohort // J Alzheimers Dis. 2014. Vol. 38, N 1. P. 201–209. doi: 10.3233/JAD-130698</mixed-citation></citation-alternatives></ref><ref id="B59"><label>59.</label><citation-alternatives><mixed-citation xml:lang="en">Han X. Lipid alterations in the earliest clinically recognizable stage of Alzheimer’s disease: implication of the role of lipids in the pathogenesis of Alzheimer’s disease. Curr Alzheimer Res. 2005;2(1):65–77. doi: 10.2174/1567205052772786</mixed-citation><mixed-citation xml:lang="ru">Han X. Lipid alterations in the earliest clinically recognizable stage of Alzheimer’s disease: implication of the role of lipids in the pathogenesis of Alzheimer’s disease // Curr Alzheimer Res. 2005. Vol. 2, N 1. P. 65–77. doi: 10.2174/1567205052772786</mixed-citation></citation-alternatives></ref><ref id="B60"><label>60.</label><citation-alternatives><mixed-citation xml:lang="en">Schengrund CL. Lipid rafts: keys to neurodegeneration. Brain Res Bull. 2010;82(1-2):7–17. doi: 10.1016/j.brainresbull.2010.02.013</mixed-citation><mixed-citation xml:lang="ru">Schengrund C.L. Lipid rafts: keys to neurodegeneration // Brain Res Bull. 2010. Vol. 82, N 1-2. P. 7–17. doi: 10.1016/j.brainresbull.2010.02.013</mixed-citation></citation-alternatives></ref><ref id="B61"><label>61.</label><citation-alternatives><mixed-citation xml:lang="en">Cutler RG, Pedersen WA, Camandola S, et al. Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress-induced death of motor neurons in amyotrophic lateral sclerosis. Ann Neurol. 2002;52(4):448–457. doi: 10.1002/ana.10312</mixed-citation><mixed-citation xml:lang="ru">Cutler R.G., Pedersen W.A., Camandola S., et al. Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress-induced death of motor neurons in amyotrophic lateral sclerosis // Ann Neurol. 2002. Vol. 52, N 4. P. 448–457. doi: 10.1002/ana.10312</mixed-citation></citation-alternatives></ref><ref id="B62"><label>62.</label><citation-alternatives><mixed-citation xml:lang="en">Cooper-Knock J, Zhang S, Kenna KP, et al. Rare variant burden analysis within enhancers identifies CAV1 as an ALS risk gene. Cell Rep. 2020;33(9):108456. Corrected and republished from: Cell Rep. 2021. Vol. 34, N 5. doi: 10.1016/j.celrep.2020.108456</mixed-citation><mixed-citation xml:lang="ru">Cooper-Knock J., Zhang S., Kenna K.P., et al. Rare variant burden analysis within enhancers identifies CAV1 as an ALS risk gene // Cell Rep. 2020. Vol. 33, N 9. P. 108456. Corrected and republished from: Cell Rep. 2021. Vol. 34, N 5. P. 108730. doi: 10.1016/j.celrep.2020.108456</mixed-citation></citation-alternatives></ref><ref id="B63"><label>63.</label><citation-alternatives><mixed-citation xml:lang="en">Zhang S, Cooper-Knock J, Weimer AK, et al. Genome-wide identification of the genetic basis of amyotrophic lateral sclerosis. Neuron. 2022;110(6):992–1008.e11. doi: 10.1016/j.neuron.2021.12.019</mixed-citation><mixed-citation xml:lang="ru">Zhang S., Cooper-Knock J., Weimer A.K., et al. Genome-wide identification of the genetic basis of amyotrophic lateral sclerosis // Neuron. 2022. Vol. 110, N 6. P. 992–1008. doi: 10.1016/j.neuron.2021.12.019</mixed-citation></citation-alternatives></ref><ref id="B64"><label>64.</label><citation-alternatives><mixed-citation xml:lang="en">Levy M, Futerman AH. Mammalian ceramide synthases. IUBMB Life. 2010;62(5):347–356. doi: 10.1002/iub.319</mixed-citation><mixed-citation xml:lang="ru">Levy M., Futerman A.H. Mammalian ceramide synthases // IUBMB Life. 2010. Vol. 62, N 5. P. 347–356. doi: 10.1002/iub.319</mixed-citation></citation-alternatives></ref><ref id="B65"><label>65.</label><citation-alternatives><mixed-citation xml:lang="en">Pradhan J, Noakes PG, Bellingham MC. The role of altered BDNF/TrkB signaling in amyotrophic lateral sclerosis. Front Cell Neurosci. 2019;13:368. doi: 10.3389/fncel.2019.00368</mixed-citation><mixed-citation xml:lang="ru">Pradhan J., Noakes P.G., Bellingham M.C. The role of altered BDNF/TrkB signaling in amyotrophic lateral sclerosis // Front Cell Neurosci. 2019. Vol. 13. P. 368. doi: 10.3389/fncel.2019.00368</mixed-citation></citation-alternatives></ref><ref id="B66"><label>66.</label><citation-alternatives><mixed-citation xml:lang="en">Mojsilovic-Petrovic J, Jeong GB, Crocker A, et al. Protecting motor neurons from toxic insult by antagonism of adenosine A2a and Trk receptors. J Neurosci. 2006;26(36):9250–9263. Corrected and republished from: J Neurosci. 2006;26(40):10079. doi: 10.1523/JNEUROSCI.1856-06.2006</mixed-citation><mixed-citation xml:lang="ru">Mojsilovic-Petrovic J., Jeong G.B., Crocker A., et al. Protecting motor neurons from toxic insult by antagonism of adenosine A2a and Trk receptors // J Neurosci. 2006. Vol. 26, N 36. P. 9250–9263. Corrected and republished from: J Neurosci. 2006. Vol. 26, N 40. P. 10079. doi: 10.1523/JNEUROSCI.1856-06.2006</mixed-citation></citation-alternatives></ref><ref id="B67"><label>67.</label><citation-alternatives><mixed-citation xml:lang="en">Petrov AM, Kravtsova VV, Matchkov VV, et al. Membrane lipid rafts are disturbed in the response of rat skeletal muscle to short-term disuse. Am J Physiol Cell Physiol. 2017;312(5):C627–C637. doi: 10.1152/ajpcell.00365.2016</mixed-citation><mixed-citation xml:lang="ru">Petrov A.M., Kravtsova V.V., Matchkov V.V., et al. Membrane lipid rafts are disturbed in the response of rat skeletal muscle to short-term disuse // Am J Physiol Cell Physiol. 2017. Vol. 312, N 5. P. C627–C637. doi: 10.1152/ajpcell.00365.2016</mixed-citation></citation-alternatives></ref><ref id="B68"><label>68.</label><citation-alternatives><mixed-citation xml:lang="en">Petrov AM, Shalagina MN, Protopopov VA, et al. Changes in membrane ceramide pools in rat soleus muscle in response to short-term disuse. Int J Mol Sci. 2019;20(19):4860. doi: 10.3390/ijms20194860</mixed-citation><mixed-citation xml:lang="ru">Petrov A.M., Shalagina M.N., Protopopov V.A., et al. Changes in membrane ceramide pools in rat soleus muscle in response to short-term disuse // Int J Mol Sci. 2019. Vol. 20, N 19. P. 4860. doi: 10.3390/ijms20194860</mixed-citation></citation-alternatives></ref><ref id="B69"><label>69.</label><citation-alternatives><mixed-citation xml:lang="en">Bryndina IG, Shalagina MN, Sekunov AV, et al. Clomipramine counteracts lipid raft disturbance due to short-term muscle disuse. Neurosci Lett. 2018;664:1–6. doi: 10.1016/j.neulet.2017.11.009</mixed-citation><mixed-citation xml:lang="ru">Bryndina I.G., Shalagina M.N., Sekunov A.V., et al. Clomipramine counteracts lipid raft disturbance due to short-term muscle disuse // Neurosci Lett. 2018. Vol. 664. P. 1–6. doi: 10.1016/j.neulet.2017.11.009</mixed-citation></citation-alternatives></ref><ref id="B70"><label>70.</label><citation-alternatives><mixed-citation xml:lang="en">Petrov AM, Naumenko NV, Uzinskaya KV, et al. Increased non-quantal release of acetylcholine after inhibition of endocytosis by methyl-β-cyclodextrin: the role of vesicular acetylcholine transporter. Neuroscience. 2011;186:1–12. Corrected and republished from: Neuroscience. 2011;192:806. doi: 10.1016/j.neuroscience.2011.04.051</mixed-citation><mixed-citation xml:lang="ru">Petrov A.M., Naumenko N.V., Uzinskaya K.V., et al. Increased non-quantal release of acetylcholine after inhibition of endocytosis by methyl-β-cyclodextrin: the role of vesicular acetylcholine transporter // Neuroscience. 2011. Vol. 186. P. 1–12. Corrected and republished from: Neuroscience. 2011. Vol. 192. P. 806. doi: 10.1016/j.neuroscience.2011.04.051</mixed-citation></citation-alternatives></ref><ref id="B71"><label>71.</label><citation-alternatives><mixed-citation xml:lang="en">Sugita S, Fleming LL, Wood C, et al. VAChT overexpression increases acetylcholine at the synaptic cleft and accelerates aging of neuromuscular junctions. Skelet Muscle. 2016;6:31. doi: 10.1186/s13395-016-0105-7</mixed-citation><mixed-citation xml:lang="ru">Sugita S., Fleming L.L., Wood C., et al. VAChT overexpression increases acetylcholine at the synaptic cleft and accelerates aging of neuromuscular junctions // Skelet Muscle. 2016. Vol. 6. P. 31. doi: 10.1186/s13395-016-0105-7</mixed-citation></citation-alternatives></ref><ref id="B72"><label>72.</label><citation-alternatives><mixed-citation xml:lang="en">Rocha MC, Pousinha PA, Correia AM, et al. Early changes of neuromuscular transmission in the SOD1(G93A) mice model of ALS start long before motor symptoms onset. PLoS One. 2013;8(9):e73846. doi: 10.1371/journal.pone.0073846</mixed-citation><mixed-citation xml:lang="ru">Rocha M.C., Pousinha P.A., Correia A.M., et al. Early changes of neuromuscular transmission in the SOD1(G93A) mice model of ALS start long before motor symptoms onset // PLoS One. 2013. Vol. 8, N 9. P. e73846. doi: 10.1371/journal.pone.0073846</mixed-citation></citation-alternatives></ref><ref id="B73"><label>73.</label><citation-alternatives><mixed-citation xml:lang="en">Petrov AM, Yakovleva AA, Zefirov AL. Role of membrane cholesterol in spontaneous exocytosis at frog neuromuscular synapses: reactive oxygen species-calcium interplay. J Physiol. 2014;592(22):4995–5009. doi: 10.1113/jphysiol.2014.279695</mixed-citation><mixed-citation xml:lang="ru">Petrov A.M., Yakovleva A.A., Zefirov A.L. Role of membrane cholesterol in spontaneous exocytosis at frog neuromuscular synapses: reactive oxygen species-calcium interplay // J Physiol. 2014. Vol. 592, N 22. P. 4995–5009. doi: 10.1113/jphysiol.2014.279695</mixed-citation></citation-alternatives></ref><ref id="B74"><label>74.</label><citation-alternatives><mixed-citation xml:lang="en">Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med. 1991;11(1):81–128. doi: 10.1016/0891-5849(91)90192-6</mixed-citation><mixed-citation xml:lang="ru">Esterbauer H., Schaur R.J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes // Free Radic Biol Med. 1991. Vol. 11, N 1. P. 81–128. doi: 10.1016/0891-5849(91)90192-6</mixed-citation></citation-alternatives></ref><ref id="B75"><label>75.</label><citation-alternatives><mixed-citation xml:lang="en">Teuling E, Ahmed S, Haasdijk E, et al. Motor neuron disease-associated mutant vesicle-associated membrane protein-associated protein (VAP) B recruits wild-type VAPs into endoplasmic reticulum-derived tubular aggregates. J Neurosci. 2007;27(36):9801–9815. doi: 10.1523/JNEUROSCI.2661-07.2007</mixed-citation><mixed-citation xml:lang="ru">Teuling E., Ahmed S., Haasdijk E., et al. Motor neuron disease-associated mutant vesicle-associated membrane protein-associated protein (VAP) B recruits wild-type VAPs into endoplasmic reticulum-derived tubular aggregates // J Neurosci. 2007. Vol. 27, N 36. P. 9801–9815. doi: 10.1523/JNEUROSCI.2661-07.2007</mixed-citation></citation-alternatives></ref><ref id="B76"><label>76.</label><citation-alternatives><mixed-citation xml:lang="en">Perry RJ, Ridgway ND. Oxysterol-binding protein and vesicle-associated membrane protein-associated protein are required for sterol-dependent activation of the ceramide transport protein. Mol Biol Cell. 2006;17(6):2604–2616. doi: 10.1091/mbc.e06-01-0060</mixed-citation><mixed-citation xml:lang="ru">Perry R.J., Ridgway N.D. Oxysterol-binding protein and vesicle-associated membrane protein-associated protein are required for sterol-dependent activation of the ceramide transport protein // Mol Biol Cell. 2006. Vol. 17, N 6. P. 2604–2616. doi: 10.1091/mbc.e06-01-0060</mixed-citation></citation-alternatives></ref><ref id="B77"><label>77.</label><citation-alternatives><mixed-citation xml:lang="en">Dupuis L, Corcia P, Fergani A, et al. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology. 2008;70(13):1004–1009. doi: 10.1212/01.wnl.0000285080.70324.27</mixed-citation><mixed-citation xml:lang="ru">Dupuis L., Corcia P., Fergani A., et al. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis // Neurology. 2008. Vol. 70, N 13. P. 1004–1009. doi: 10.1212/01.wnl.0000285080.70324.27</mixed-citation></citation-alternatives></ref><ref id="B78"><label>78.</label><citation-alternatives><mixed-citation xml:lang="en">Zheng Z, Sheng L, Shang H. Statins and amyotrophic lateral sclerosis: a systematic review and meta-analysis. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14(4):241–245. doi: 10.3109/21678421.2012.732078</mixed-citation><mixed-citation xml:lang="ru">Zheng Z., Sheng L., Shang H. Statins and amyotrophic lateral sclerosis: a systematic review and meta-analysis // Amyotroph Lateral Scler Frontotemporal Degener. 2013. Vol. 14, N 4. P. 241–245. doi: 10.3109/21678421.2012.732078</mixed-citation></citation-alternatives></ref><ref id="B79"><label>79.</label><citation-alternatives><mixed-citation xml:lang="en">Krivoi II, Petrov AM. Cholesterol and the safety factor for neuromuscular transmission. Int J Mol Sci. 2019;20(5):1046. doi: 10.3390/ijms20051046</mixed-citation><mixed-citation xml:lang="ru">Krivoi I.I., Petrov A.M. Cholesterol and the safety factor for neuromuscular transmission // Int J Mol Sci. 2019. Vol. 20, N 5. P. 1046. doi: 10.3390/ijms20051046</mixed-citation></citation-alternatives></ref><ref id="B80"><label>80.</label><citation-alternatives><mixed-citation xml:lang="en">Ingre C, Chen L, Zhan Y, et al. Lipids, apolipoproteins, and prognosis of amyotrophic lateral sclerosis. Neurology. 2020;94(17):e1835–e1844. doi: 10.1212/WNL.0000000000009322</mixed-citation><mixed-citation xml:lang="ru">Ingre C., Chen L., Zhan Y., et al. Lipids, apolipoproteins, and prognosis of amyotrophic lateral sclerosis // Neurology. 2020. Vol. 94, N 17. P. e1835–e1844. doi: 10.1212/WNL.0000000000009322</mixed-citation></citation-alternatives></ref></ref-list></back></article>
